|Gonzalez (left) and Rodriguez (right) during the 2012 postseason. (US Presswire)|
Yankees third baseman Alex Rodriguez and Nationals left-hander Gio Gonzalez have denied performance-enhancing drug allegations stemming from their connections to a South Florida clinic. A-Rod's camp issued a statement...
The news report about a purported relationship between Alex Rodriguez and Anthony Bosch are not true. Alex Rodriguez was not Mr. Bosch's patient, he was never treated by him and he was never advised by him. The purported documents referenced in the story -- at least as they relate to Alex Rodriguez -- are not legitimate.
...while Gonzalez took to Twitter for his denial...
I've never used performance enhancing drugs of any kind and I never will ,I've never met or spoken with tony Bosch orused any substance— Gio Gonzalez (@GioGonzalez47) January 29, 2013
Provided by him.anything said to the contrary is a lie.— Gio Gonzalez (@GioGonzalez47) January 29, 2013
The Miami New Times, in a report released on Tuesday, detailed a relationship Rodriguez and Gonzalez -- and other prominent players -- had with the clinic's director, Anthony Bosch. MLB and the DEA are already investigating Bosch.
Rodriguez, 37, hit .272/.353/.430 with 18 homers in 122 games last season. A-Rod admitted using PEDs while with the Texas Rangers from 2001-2003 back in 2009, but the newest allegations stem from PED use from 2009-2012. Rodriguez will miss the first half of next season due to left hip surgery and is still owed $114 million over the next five years.
Gonzalez, 27, went 21-8 with a 2.89 ERA last season, his first with the Nationals after being acquired from the Athletics last winter. He signed a five-year, $42 million contract extension last January.
Rodriguez has hired attorney Roy Black, according to Jon Heyman of CBSSports.com. Black helped William Kennedy Smith win his acquittal back in 1991.
For more baseball news, rumors and analysis, follow @EyeOnBaseball on Twitter, subscribe to the RSS feed and "like" us on Facebook. Also, individually interact with us on Twitter: @MattSnyder27, @daynperry and @mikeaxisa.